fitness to drive (cardiac)

in review 6 min read Updated 2026-10-22
CCS 2023 sets driving limits by the annual risk of sudden cardiac incapacitation (SCI): ≤22%/year acceptable for private drivers, ≤1%/year for commercial. Short post-event stand-downs (after ACS, PCI, CABG, devices) are expert consensus for transient risk, not the formula. With more than one condition, the most restrictive rule applies. Restrictions run from the procedure date, or from discharge if no intervention. Volatile detail → check the current CCS guideline and provincial rules.

risk of harm formula

  • Benchmark: a commercial driver with 1% annual SCI risk → 1 in 20,000/year risk of death or serious injury to others
  • Private drivers spend less time driving, in smaller vehicles → same societal harm at 22% annual SCI risk
  • Commercial = any commercial licence class (trucks, buses, taxis), not only tractor-trailers

coronary disease

conditionprivatecommercial
STEMI or NSTEMI + PCI, LVEF >40%2 weeks1 month
STEMI or NSTEMI + PCI, LVEF ≤40%1 month3 months
STEMI or NSTEMI, no PCI1 month3 months
unstable angina + PCI48 h7 days
unstable angina, no PCI7 days1 month
elective PCI48 h48 h
CABG1 month3 months
stable angina or asymptomatic CADno restrictionno restriction
  • Untreated left main stenosis disqualifies: ≥50% commercial, ≥70% private
  • ACS with non-obstructive coronaries → treat as revascularised; LVEF drives the decision → MINOCA
  • Ongoing LV dysfunction → HF rules below; ICD → device rules. Post-MI management → post-MI care

heart failure, LVAD, transplant

conditionprivatecommercial
NYHA I–IIno restrictiondisqualified if LVEF <30%
NYHA IIIno restrictiondisqualified
NYHA IVdisqualifieddisqualified
intermittent outpatient or home inotropesdisqualifieddisqualified
LVAD≥2 months post-implant + NYHA I–IIdisqualified
heart transplant≥6 weeks post-discharge, NYHA I–II≥6 months, NYHA I, LVEF ≥50%

valvular disease

Untreated (medically managed):

lesionprivate: drive ifcommercial: drive if
ASNYHA I–IINYHA I, no impaired consciousness, LVEF ≥50%
AR, MR, MS, TRNYHA I–IIINYHA I, no impaired consciousness, LVEF ≥50% (except MS)
  • symptomatic severe AS (NYHA III–IV) → no private driving until treated → aortic stenosis

After intervention:

procedureprivatecommercial
TAVI (AS or AR)1 month3 months
valve surgery1 month3 months
TEER; balloon mitral valvuloplasty48 h1 month
  • commercial after any valve intervention: NYHA I and LVEF ≥30%
  • after TAVI/AVR: no new high-grade AV block unless paced

arrhythmias

ventricular arrhythmias

conditionprivatecommercial
VF without reversible cause3 monthsdisqualified
unstable VT, or VT with impaired consciousness3 monthsdisqualified
sustained VT, structural heart disease, conscious, no ICD3 monthsdisqualified
sustained idiopathic VT (normal heart), conscious1 week once controlleddisqualified
VT/VF from reversible cause (VF <24 h of MI, during angiography, electrocution, drug toxicity)until cause treateduntil cause treated

ICD whenever indicated → ventricular arrhythmias and sudden cardiac death

SVT, AF, flutter

  • No impaired consciousness → no restriction (both classes)
  • With impaired consciousness → disqualified until satisfactory control
  • After EP study or ablation → 48 h if no new conduction disturbance or arrhythmia
  • Acute management → approach to tachyarrhythmias, atrial fibrillation

bradycardia and conduction disease

Asymptomatic conduction disease → no restriction for either class: first-degree AVB, isolated RBBB/LAFB/LPFB, LBBB, bifascicular block (± first-degree AVB), Mobitz I, congenital complete heart block. Any impaired consciousness → disqualified until device therapy.

Disqualified (both classes) until pacemaker:

  • Mobitz II, alternating BBB, acquired complete heart block (or resolution of a reversible cause, e.g. inferior STEMI, Lyme carditis)
  • Sinus node dysfunction with impaired consciousness
  • Symptomatic pauses ≥5 s in AF or on conversion

Pacing indications → bradyarrhythmias and pacemakers.


pacemakers and ICDs

pacemakers

situationprivate and commercial
new pacemaker (transvenous or leadless) after impaired consciousness or high-grade AVB1 week
new pacemaker, no impaired consciousness or high-grade AVBno restriction
generator changeno restriction

ICDs (transvenous or subcutaneous)

Commercial driving: disqualified with any ICD, because of the underlying condition (LV dysfunction, VA history), not the device.

situationprivate
primary prevention1 week after implant
secondary prevention: VF, or VT with impaired consciousness3 months after last incapacitating event
secondary prevention: sustained VT, conscious1 week after implant
appropriate shock, disabling (or unknown, e.g. during sleep)3 months
appropriate shock, not disabling1 week
inappropriate therapy; generator changeno restriction

inherited arrhythmia syndromes and cardiomyopathies

  • private: no restriction if asymptomatic; 3 months after arrhythmic syncope, cardiac arrest or sustained VA (ICD doesn’t change this)
  • commercial: individual expert assessment — high-risk features (syncope, arrest, HCM high-risk markers, definite ARVC, LQTS with QTc >500 or syncope) usually disqualify
  • gene-positive relatives without disease → no restriction
  • HCM risk stratification → hypertrophic cardiomyopathy

syncope

situationprivatecommercial
vasovagal, single or recurrentno restrictionno restriction
reversible or treated cause (orthostatic, haemorrhage, dehydration)1 week1 month
situational with avoidable trigger (micturition, defecation)1 week1 month
unexplained, single1 week12 months
unexplained, recurrent within 12 months3 months12 months
arrhythmic, or diagnosed and treatedper arrhythmia and device rulesper arrhythmia and device rules

other conditions

  • Aortic aneurysm: not covered by CCS 2023 → size limits (CCS 2014) in aortic aneurysm

reporting

  • Ontario: physicians, NPs and optometrists must report conditions causing sudden incapacitation (among other categories) to MTO under Highway Traffic Act s.203, using the Medical Condition Report. A mandatory report → licence suspension. Discretionary reports of other unsafe conditions do not automatically suspend. Telling the patient beforehand is encouraged; consent is not required → MTO medical reporting
  • Document the advice given (stop driving, duration) in the chart
  • Duty to report, counselling and non-cardiac conditions: CMA Driver’s Guide

Prepared 2026-10-22. Not yet verified — check every number against the sources.

Key references

+1 more source

Suggest a correction fitness to drive (cardiac)